SEC Form 4 · accession 0001443197-18-000002
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl Desantis
Director · 10% Owner
Period of report
Jul 31, 2018
Accepted (ET)
Aug 1, 2018 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016504
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 31, 2018 | J | 8,230,769 | $0.65 | A | 117,409 | D | |
| Common StockF3 | holding | — | — | — | 12,766,982 | I | 1 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6% secured convertible note due 2020, as amendedF1,F4 | $0.65 | Jul 24, 2018 | C | — | D | Jun 27, 2012 | Feb 29, 2020 | Common Stock | 8,230,769 | 0 | I |
Explanation of responses
- F1Common stock issued to CD Financial, LLC as the result of CD Financial, LLC exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by CD Financial, LLC of which the Reporting Person is a member.
- F2Includes 100,000 shares of common stock issuable upon exercise of presently exercisable stock options.
- F3Includes (i) 10,524,173 shares of common stock owned by CD Financial LLC of which the Reporting Person is a member and (ii) 2,242,809 shares of common stock owned by Carl DeSantis Revocable Trust.
- F4On July 31, 2018, the Issuer issued 8,230,769 shares upon the receipt of a conversion notice from CD Financial, LLC settling the 6% secured convertible note in full.